Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$216M |
| 2 |
Charter Communications
CHTR
|
+$192M |
| 3 |
SLB Ltd
SLB
|
+$79.3M |
| 4 |
IBM
IBM
|
+$70.2M |
| 5 |
Newell Brands
NWL
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AFFX
Affymetrix Inc
AFFX
|
+$7.53B |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$447M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$229M |
| 4 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$208M |
| 5 |
SANDISK CORP
SNDK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.87% |
| 2 | Technology | 14.38% |
| 3 | Financials | 13.98% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3876
Ceragon Networks
CRNT
$186M
| $42K | ﹤0.01% |
26,165
| – | – |
2015 Q1
5 quarters
|
|
|
MATN
3877
DELISTED
Mateon Therapeutics, Inc.
MATN
| $42K | ﹤0.01% |
+60,393
| New | +$42.8K |
2016 Q2
0 quarters
|
|
|
NSPH
3878
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $42K | ﹤0.01% |
24,637
| – | – |
2013 Q2
12 quarters
|
|
3879
Westwater Resources
WWR
$52.1M
| $41K | ﹤0.01% |
513
| – | – |
2013 Q2
12 quarters
|
|
|
XPLR
3880
DELISTED
Xplore Technologies Corp.
XPLR
| $40K | ﹤0.01% |
16,945
| – | – |
2015 Q1
5 quarters
|
|
|
FAC
3881
DELISTED
First Acceptance Corp.
FAC
| $40K | ﹤0.01% |
28,734
| – | – |
2013 Q2
12 quarters
|
|
3882
Gyre Therapeutics
GYRE
$645M
| $39K | ﹤0.01% |
228
| – | – |
2013 Q2
12 quarters
|
|
3883
DELISTED
Sonnet BioTherapeutics
SONN
| – | – |
0
| – | – |
2015 Q2
4 quarters
|
|
3884
Viking Therapeutics
VKTX
$3.2B
| $39K | ﹤0.01% |
+31,264
| New | +$41.2K |
2016 Q2
0 quarters
|
|
3885
Westport Fuel Systems
WPRT
$34.4M
| $39K | ﹤0.01% |
2,352
-446
| -16% | -$9.6K |
2013 Q2
12 quarters
|
|
3886
Solitario Resources
XPL
$48.7M
| $39K | ﹤0.01% |
75,942
| – | – |
2013 Q2
12 quarters
|
|
|
IMNP
3887
DELISTED
Immune Pharmaceuticals Inc.
IMNP
| $39K | ﹤0.01% |
4,996
| – | – |
2015 Q3
3 quarters
|
|
|
JRJR
3888
DELISTED
JRjr33, Inc.
JRJR
| $39K | ﹤0.01% |
44,389
| – | – |
2016 Q1
1 quarter
|
|
3889
Cineverse
CNVS
$38.3M
| $38K | ﹤0.01% |
1,604
| – | – |
2013 Q2
12 quarters
|
|
3890
Q/C Technologies Inc
QCLS
$4.28M
| – | – |
0
| – | – |
2014 Q3
7 quarters
|
|
3891
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
| $38K | ﹤0.01% |
+3
| New | +$51.1K |
2016 Q2
0 quarters
|
|
|
ACUR
3892
DELISTED
Acura Pharmaceuticals
ACUR
| $38K | ﹤0.01% |
21,024
| – | – |
2013 Q2
12 quarters
|
|
3893
Lightpath Technologies
LPTH
$536M
| $37K | ﹤0.01% |
21,491
| – | – |
2013 Q2
12 quarters
|
|
3894
Wheeler Real Estate Investment Trust
WHLR
$211K
| – | – |
0
| – | – |
2014 Q3
7 quarters
|
|
|
EPRS
3895
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $37K | ﹤0.01% |
82,821
| – | – |
2014 Q3
7 quarters
|
|
|
ALBO
3896
DELISTED
Albireo Pharma Inc
ALBO
| $36K | ﹤0.01% |
3,902
| – | – |
2013 Q2
12 quarters
|
|
|
EVFM
3897
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $35K | ﹤0.01% |
399
| – | – |
2015 Q1
5 quarters
|
|
|
ERN
3898
DELISTED
Erin Energy Corp
ERN
| $34K | ﹤0.01% |
14,124
+2,625
| +23% | +$5.5K |
2015 Q3
3 quarters
|
|
|
DSKX
3899
DELISTED
DS HEALTHCARE GROUP, INC. NEW COMMON STOCK
DSKX
| $34K | ﹤0.01% |
52,113
| – | – |
2015 Q2
4 quarters
|
|
|
IFO
3900
DELISTED
INFOSONICS CORPORATION
IFO
| $34K | ﹤0.01% |
41,938
| – | – |
2014 Q1
9 quarters
|
|
Similar funds
Geode Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, down 2.4% from $188B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Geode Capital Management withdrew a net $8.49B in Q2 2016, closing 127 positions and reducing 984 holdings. Its most notable exit was Affymetrix Inc, an estimated $7.53B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Geode Capital Management opened a new position in S&P Global worth $215M.
- Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
- Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
- Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
- Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53B.
- Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
- Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
- Geode Capital Management's portfolio value fell 2.4% quarter-over-quarter to $184B.
Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.